BiotechTube
Home/Pipeline/NVC-001B

NVC-001B

Undisclosed

PreclinicalActive

Key Facts

Indication
Undisclosed
Phase
Preclinical
Status
Active
Company
Nuevocor

About Nuevocor

Mechanobiology‑focused gene therapy company targeting rare cardiomyopathies.

View full company profile

Therapeutic Areas

CardiovascularGenetic Cardiomyopathy

Other Undisclosed Drugs

DrugCompanyPhase
Preclinical ISAC 1Bolt BiotherapeuticsPreclinical
Preclinical ISAC 2Bolt BiotherapeuticsPreclinical
ART12.11Artelo BiosciencesPreclinical
Novel VaccinesMSDDevelopment
SLS-009Seelos TherapeuticsDiscovery
Technosphere Platform (New Formulations)MannKindDiscovery/Preclinical
Measovir®-based Prophylactic Vaccine (with Unither)OncovitaResearch/Pre-clinical
Internal sdAb Discovery ProgramNanoTag BiotechnologiesDiscovery
NB-701Nerai BiosciencesDiscovery
Undisclosed Therapeutic Program(s)Bright CellClinical Trial (Phase unspecified)
Biosimilars PipelineIntelligent TherapeuticsPre-clinical/Development
Proprietary Therapeutic PipelineExcelsior SciencesDiscovery